We are live on
!
Find out more
FNBT
FineMark National Bank & Trust Portfolio holdings
AUM
$3.2B
1-Year Est. Return
18.28%
This Fund
S&P 500
This Quarter
Est. Return
-3.85%
1 Year Est. Return
+18.28%
3 Year Est. Return
+69.81%
5 Year Est. Return
+87.67%
10 Year Est. Return
+274.39%
AUM
$2.3B
AUM Growth
-$135M
(-5.5%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
37.6%
Holding
445
New
14
Increased
103
Reduced
220
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$8.61M |
| 2 |
Intuitive Surgical
ISRG
|
+$5.64M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$4.95M |
| 4 |
Exelon
EXC
|
+$3.85M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$3.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$5.55M |
| 2 |
Becton Dickinson
BDX
|
+$5.39M |
| 3 |
L3Harris
LHX
|
+$5.35M |
| 4 |
Avantor
AVTR
|
+$3.8M |
| 5 |
Union Pacific
UNP
|
+$3.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.2% |
| 2 | Technology | 15.89% |
| 3 | Financials | 8.4% |
| 4 | Healthcare | 8.32% |
| 5 | Consumer Discretionary | 6.52% |
Similar funds
UOC
SAG
ACI
RC
A
CGL
CB
JCM
FineMark National Bank & Trust's Q3 2023 Portfolio in Review
As of Q3 2023, FineMark National Bank & Trust held 445 positions worth $2.3B, down 5.5% from $2.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FineMark National Bank & Trust's Q3 2023 filing shows 14 new, 103 increased, 220 reduced and 28 closed positions. Its largest new stake was Marsh: 16,517 shares worth $3.14M. The largest sale was CVS Health, an estimated $5.55M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
- FineMark National Bank & Trust's largest Q3 2023 buy was Marsh: 16,517 shares worth $3.14M.
- FineMark National Bank & Trust added most to Thermo Fisher Scientific in Q3 2023, an estimated $8.61M increase.
- FineMark National Bank & Trust's biggest Q3 2023 reduction was CVS Health, cutting an estimated $5.55M.
- FineMark National Bank & Trust fully exited Align Technology in Q3 2023, selling an estimated $461K.
- FineMark National Bank & Trust's ten largest holdings make up 38% of its $2.3B portfolio in Q3 2023.
- FineMark National Bank & Trust opened 14 new positions and closed 28 in Q3 2023.
- FineMark National Bank & Trust's portfolio value fell 5.5% quarter-over-quarter to $2.3B.
Based on FineMark National Bank & Trust's 13F filing for Q3 2023, filed 13 Nov 2023.